Our Vaccine Trials
This study is testing a new investigational influenza vaccine to find the safest and most effective dose for better prevention of influenza outbreaks in healthy adults aged 18-49.
This study is being conducted at our Canberra and Western Sydney Clinics.
Apply NowPhase 1 study to Investigate the Safety and Immunogenicity of a Combined Respiratory Syncytial Virus/human Metapneumovirus/Parainfluenza Virus type 3 investigational mRNA Vaccine Candidate in Adult Participants Aged 60 Years and Older.
This study is being conducted at our Central Coast, Brisbane and Western Sydney sites.
Apply NowA Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.
This study is being conducted at our Brisbane site.
Apply NowThis study is researching whether an investigational vaccine is safe, well-tolerated and is able to protect against norovirus gastroenteritis, a virus that can cause gastro.
This study is being conducted at our Brisbane, Central Coast and Canberra sites.
Apply NowParatus Clinical are conducting a trial evaluating new potential vaccines for respiratory illnesses like the flu, RSV, hMPV, and PIV3. If you’re aged 18 to 49 and healthy, you may be eligible to participate in this 6-month study. Reimbursement will be provided for participation.
This study is being conducted at our Western Sydney and Brisbane clinics.
Apply Now